Atlas Trials

INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study

Clinical trial NCT04505566 · COMPLETED

Trial details

NCT number
NCT04505566
Sponsor
Stephen J. Kim, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetic Retinopathy
Start date
2020-11-09
Primary completion
2026-04-21
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.